![Jian Qiang Li](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jian Qiang Li
Fondatore presso Hebei Senlangbio Biotechnology Co., Ltd.
Posizioni attive di Jian Qiang Li
Società | Posizione | Inizio | Fine |
---|---|---|---|
Hebei Senlangbio Biotechnology Co., Ltd.
![]() Hebei Senlangbio Biotechnology Co., Ltd. BiotechnologyHealth Technology Hebei Senlangbio Biotechnology Co., Ltd. is a clinical-stage biotechnology company based in Shijiazhuang, China. The Chinese company is dedicated to utilizing cell and gene engineering technologies to generate innovative and transformative cellular immunotherapies for solid and hematologic cancers. Senlangbio has three cell therapy technology platforms, including chimeric antigen receptor (CAR) T-cells (CAR-T), allogeneic CAR gamma delta T-cells (CAR-GDT), and armored tumor infiltrating lymphocytes (armTILs). Senlangbio is currently the largest cell therapy company in terms of the scale of bio-manufacturing, as well as the breadth and depth of active pre-clinical research and clinical development programs. The private company is in the process of further capturing the cell therapy markets in other regions and planning for international multi-center clinical studies. The company was founded in 2016 by Jian Qiang Li. | Direttore/Membro del Consiglio | - | - |
Direttore Tecnico/Scientifico/R&S | 01/06/2016 | - | |
Fondatore | 28/01/2016 | - | |
Presidente | 01/06/2016 | - |
Storia della carriera di Jian Qiang Li
Formazione di Jian Qiang Li
Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Peking Union Medical College | Graduate Degree |
Statistiche
Distribuzione geografica
Cina | 3 |
Germania | 2 |
Posizioni
Director/Board Member | 1 |
Chairman | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Hebei Senlangbio Biotechnology Co., Ltd.
![]() Hebei Senlangbio Biotechnology Co., Ltd. BiotechnologyHealth Technology Hebei Senlangbio Biotechnology Co., Ltd. is a clinical-stage biotechnology company based in Shijiazhuang, China. The Chinese company is dedicated to utilizing cell and gene engineering technologies to generate innovative and transformative cellular immunotherapies for solid and hematologic cancers. Senlangbio has three cell therapy technology platforms, including chimeric antigen receptor (CAR) T-cells (CAR-T), allogeneic CAR gamma delta T-cells (CAR-GDT), and armored tumor infiltrating lymphocytes (armTILs). Senlangbio is currently the largest cell therapy company in terms of the scale of bio-manufacturing, as well as the breadth and depth of active pre-clinical research and clinical development programs. The private company is in the process of further capturing the cell therapy markets in other regions and planning for international multi-center clinical studies. The company was founded in 2016 by Jian Qiang Li. | Health Technology |
- Borsa valori
- Insiders
- Jian Qiang Li
- Esperienza